BBH ETF

$184.76

Returns Overview

1 Month
-3.16%
3 Months
-6.12%
6 Months
-3.86%
YTD
-2.88%
1 Year
+20.90%
3 Years
+8.77%
5 Years
+2.55%
10 Years
+7.50%

Risk Metrics (1-Year)

No risk data available for this ETF

Stress Test Scenarios

How would BBH have held up?
🦠COVID-19 Crash33 days
Market peak to trough during pandemic sell-off
Run Analysis
📈2022 Rate Hikes9 months
Fed aggressive rate hiking cycle bear market
🔒Upgrade to run
📉2018 Q4 Selloff3 months
Trade war fears and Fed tightening
🔒Upgrade to run
🏦SVB / Banking Crisis5 days
Regional banking contagion fears
🔒Upgrade to run

1 Month Performance

-3.16%

3 Months Performance

-6.12%

6 Months Performance

-3.86%

1 Year Performance

+20.90%

Benchmark & Peers

Benchmark
MVIS US Listed Biotech 25 Index(^MVBBH)
This ETF (YTD)
-2.88%
Peer Avg (YTD)
+1.55%
vs Peers
-4.42%

BBH ETF Performance

BBH performance across multiple time periods: 1-month -3.16%, YTD -2.88%, 1-year 20.90%, 3-year 8.77%, 5-year 2.55%, 10-year 7.50%.

BBH returns trail the peer average of 1.55% YTD. With an expense ratio of 0.35%, investors should weigh costs against performance when evaluating this ETF.

BBH performance comparison shows side-by-side returns with another fund. BBH alternatives are available in the ETF Screener.

Performance & Returns

Loading chart...

Performance Returns

PeriodTotal ReturnDate Range
1 Month-3.16%Apr 22, 2026 to May 22, 2026
3 Months-6.12%Feb 23, 2026 to May 22, 2026
6 Months-3.86%Nov 24, 2025 to May 22, 2026
1 Year+20.90%N/A
3 Years+8.77%N/A
5 Years+2.55%N/A

All returns shown are total returns, not annualized